Timber Hill’s Biogen BIIB Stock Holding History

Timber Hill’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,910	Closed	-$1.34M	–	96
2018 Q1	$1.34M	Buy	4,910 +49	+1%	+$15.2K	0.21%	104
2017 Q4	$1.55M	Buy	+4,861	New	+$1.56M	0.1%	205
2017 Q1	–	Sell	-4,623	Closed	-$1.31M	–	2119
2016 Q4	$1.31M	Sell	4,623 -359	-7%	-$106K	0.01%	1124
2016 Q3	$1.56M	Buy	+4,982	New	+$1.48M	0.01%	893
2015 Q3	–	Sell	-8,345	Closed	-$2.76M	–	2400
2015 Q2	$3.37M	Buy	8,345 +3,886	+87%	+$1.56M	0.02%	778
2015 Q1	$1.88M	Buy	+4,459	New	+$1.76M	0.01%	1072
2014 Q3	–	Sell	-4,740	Closed	-$1.56M	–	2576
2014 Q2	$1.5M	Sell	4,740 -11,823	-71%	-$3.56M	0.01%	1390
2014 Q1	$5.07M	Buy	16,563 +1,392	+9%	+$442K	0.02%	635
2013 Q4	$4.24M	Sell	15,171 -20,009	-57%	-$5.18M	0.02%	866
2013 Q3	$8.47M	Buy	+35,180	New	+$7.87M	0.03%	546

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Timber Hill's BIIB Position: Q2 2018 in Review

Timber Hill sold out of Biogen (BIIB) in Q2 2018, closing a stake of 4,910 shares — an estimated $1.34M sold.

Timber Hill first reported a position in BIIB in Q3 2013 and held it in 10 quarters. The position peaked at $8.47M in Q3 2013. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

Timber Hill reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
Timber Hill sold 4,910 Biogen shares in Q2 2018, an estimated $1.34M.
Timber Hill first reported a position in Biogen in Q3 2013 and held it in 10 quarters.
Timber Hill's Biogen position peaked at $8.47M in Q3 2013.
1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.